RT Journal Article
SR Electronic
T1 The MultimorbiditY COllaborative Medication Review And DEcision Making (MyComrade) study: A protocol for a cross-border pilot cluster randomised controlled trial
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.16.21263674
DO 10.1101/2021.09.16.21263674
A1 Hynes, Lisa
A1 Murphy, Andrew W
A1 Hart, Nigel
A1 Kirwan, Collette
A1 Mulligan, Sarah
A1 Leathem, Claire
A1 McQuillan, Laura
A1 Maxwell, Marina
A1 Carr, Emma
A1 Walkin, Scott
A1 McCarthy, Caroline
A1 Bradley, Colin
A1 Byrne, Molly
A1 Smith, Susan M
A1 Hughes, Carmel
A1 Corry, Maura
A1 Kearney, Patricia M
A1 McCarthy, Geraldine
A1 Cupples, Margaret
A1 Gillespie, Paddy
A1 Newell, John
A1 Glynn, Liam
A1 Alvarez-Iglesias, Alberto
A1 Sinnott, Carol
YR 2021
UL http://medrxiv.org/content/early/2021/09/22/2021.09.16.21263674.abstract
AB Background While international guidelines recommend medication reviews as part of the management of multimorbidity, evidence on how to implement reviews in practice in primary care is lacking. The MyComrade (MultimorbiditY Collaborative Medication Review And Decision Making) intervention is an evidence-based, theoretically-informed novel intervention which aims to support the conduct of medication reviews for patients with multimorbidity in primary care. Our aim in this pilot study is to evaluate the feasibility of a trial of the intervention with unique modifications accounting for contextual variations in two neighbouring health systems (Republic of Ireland (ROI) and Northern Ireland (NI)).Methods A pilot cluster randomised controlled trial will be conducted, using a mixed methods process evaluation to investigate the feasibility of a trial of the MyComrade intervention. A total of 16 practices will be recruited (eight in ROI; eight in NI) and four practices in each jurisdiction will be randomly allocated to intervention or control. Twenty people living with multimorbidity and prescribed ≥10 repeat medications will be recruited from each practice prior to practice randomisation. In intervention practices, the MyComrade intervention will be delivered by pairs of GPs in ROI, and a GP and Practice Based Pharmacist (PBP) in NI. The GPs/GP and PBP will schedule time to review medications together using a checklist. Usual care will proceed in practices in the control arm. Data will be collected via electronic health records and postal questionnaires at recruitment, and 4- and 8-months after randomisation. Qualitative interviews to assess the feasibility and acceptability of the intervention, and explore experiences related to multimorbidity management will be conducted with a purposive sample of GPs, PBPs, practice administration staff and patients in intervention and control practices. The feasibility of conducting a health economic evaluation as part of a future definitive trial will be assessed.Discussion The findings of this pilot study will assess the feasibility of a trial of the MyComrade intervention in two different health systems. Evaluation of the progression criteria will guide the decision to progress to a definitive trial and inform trial design. The findings will also contribute to the growing evidence-base related to intervention development and feasibility studies.Trial registration Registry: ISRCTN, ISRCTN80017020; Date of confirmation 4/11/2019; Retrospectively registered; http://www.isrctn.com/ISRCTN80017020.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN80017020Funding StatementHSC R&D Division Cross-border Healthcare Intervention Trials in Ireland Network (CHITIN), UK and Ireland. The views and opinions expressed in this protocol do not necessarily reflect those of the European Commission or the Special EU Programmes Body (SEUPB).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval and consent to participate: Ethical approval has been granted by the Irish College of General Practitioners Research Ethics Committee (ROI) and the Office of Research Ethics Committees Northern Ireland (ORECNI; REC reference 19/NI/0120; IRAS ID 260425). Informed consent was obtained before recruiting participants.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referenced in this protocol are available on request from the corresponding authorcRCTCluster Randomised Controlled TrialGPGeneral PractitionerHRB PC CTNIHealth Research Board Primary Care Clinical Trials Network of IrelandMCMyComradeMRCMedical Research CouncilNINorthern IrelandNICENational Institute for Health and Care ExcellenceNICRNNorthern Ireland Clinical Research NetworkORECNIOffice of Research Ethics Committees Northern IrelandPBPPractice Based PharmacistQALYsQuality Adjusted Life-YearsROIRepublic of IrelandTIDieRTemplate for Intervention Description and Replication